Integrative cluster classification to predict pathological complete response to neoadjuvant chemotherapy in early breast cancer

被引：2
|
作者：
Alba, Emilio
Rueda, Oscar M.
Lluch, Ana
Albanell, Joan
Chin, Suet-Feung
Chacon, Jose Ignacio
Calvo, Lourdes
De La Haba, Juan
Bermejo, Begona
Ribelles, Nuria
Cirauqui, Beatriz
Ramos Vazquez, Manuel
Arcusa Lanza, Maria Angeles
Maria Carrasco, Eva
Herranz, Jesus
Chiesa, Massimo
Caballero, Rosalia
Santonja Climent, Angela
Rojo, Federico
Caldas, Carlos
机构：
[1] Hosp Clin Univ Virgen de la Victoria, GEICAM Spanish Breast Canc Grp, Malaga, Spain
[2] Canc Res UK Cambridge Inst, Cambridge, England
[3] Hosp Clin Univ Valencia, GEICAM Spanish Breast Canc Grp, Ctr Invest Biomed Red Oncol, CIBERONC ISCIII, Valencia, Spain
[4] Hosp del Mar, GEICAM Spanish Breast Canc Grp, Barcelona, Spain
[5] Canc Res UK, Cambridge Res Inst, Cambridge, England
[6] Hosp Virgen de la Salud, GEICAM Spanish Breast Canc Grp, Toledo, Spain
[7] Complejo Hosp Univ A Coruna, GEICAM Spanish Breast Canc Grp, La Coruna, Spain
[8] Univ Cordoba, Biomed Res Inst Maimonides, Hosp Univ Reina Sofia, Cordoba, Spain
[9] Spanish Breast Canc Grp, Ctr Invest Biomed Red Oncol, CIBERONC ISCIII GEICAM, Cordoba, Spain
[10] Hosp Univ Reg & Virgen de la Victoria Malaga, IBIMA, Unidad Gest Clin Interctr Oncol, Malaga, Spain
[11] Hosp Badalona Germans Trias & Pujol, Med Oncol Dept, Catalan Inst Oncol, Badalona, Spain
[12] GEICAM Spanish Breast Canc Grp, Ctr Oncol Galicia, La Coruna, Spain
[13] Hosp Terrassa, GEICAM Spanish Breast Canc Grp, Barcelona, Spain
[14] GEICAM Spanish Breast Canc Grp, Madrid, Spain
[15] Hosp Clin Univ Virgen de la Victoria, Malaga, Spain
[16] Fdn Jimenez Diaz, Madrid, Spain
[17] CIBERONC ISCIII, Ctr Invest Biomed Red Oncol, Madrid, Spain
[18] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.579
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
579
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Model based on ultrasound and clinicopathological characteristics for early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
    Wen, Xin
    Chen, Jiamin
    Zhong, Jing
    Zhuang, Yu
    Deng, Bixue
    Lin, Yuhong
    Su, Zhongzhen
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2024, 14 (12) : 8840 - 8851
  • [32] Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
    Jung, Ji-Jung
    Kim, Eun-Kyu
    Kang, Eunyoung
    Kim, Jee Hyun
    Kim, Se Hyun
    Suh, Koung Jin
    Kim, Sun Mi
    Jang, Mijung
    Yun, Bo La
    Park, So Yeon
    Lim, Changjin
    Han, Wonshik
    Shin, Hee-Chul
    JOURNAL OF BREAST CANCER, 2023, 26 (04) : 353 - 362
  • [33] Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
    Kawajiri, Hidemi
    Takashima, Tsutomu
    Aomatsu, Naoki
    Kashiwagi, Shinichiro
    Noda, Satoru
    Onoda, Naoyoshi
    Ishikawa, Tetsurou
    Hirakawa, Kosei
    ONCOLOGY LETTERS, 2014, 7 (03) : 663 - 668
  • [34] Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer
    Liu, Rong
    Lv, Qiao-Li
    Yu, Jing
    Hu, Lei
    Zhang, Li-Hua
    Cheng, Yu
    Zhou, Hong-Hao
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (03) : 607 - 618
  • [35] Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer
    Rong Liu
    Qiao-Li Lv
    Jing Yu
    Lei Hu
    Li-Hua Zhang
    Yu Cheng
    Hong-Hao Zhou
    Breast Cancer Research and Treatment, 2015, 151 : 607 - 618
  • [36] Prediction of pathological complete response by microRNA in breast cancer patients treated with neoadjuvant chemotherapy
    Shimomura, Akihiko
    Shiino, Sho
    Kawauchi, Junpei
    Takizawa, Satoko
    Ichikawa, Makiko
    Matsuzaki, Juntaro
    Sakamoto, Hiromi
    Kinoshita, Takayuki
    Tamura, Kenji
    Ochiya, Takahiro
    CANCER SCIENCE, 2018, 109 : 394 - 394
  • [37] Neoadjuvant chemotherapy for breast cancer: Nodal downstaging is highly correlated with pathological complete response
    Blumencranz, P.
    Habibi, M.
    Treece, T.
    Blumencranz, L.
    Yoder, E.
    Audeh, W.
    Carter, E.
    McNaughton, L.
    Roussos, J.
    Shivers, S.
    Acs, G.
    Cox, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [38] Platelet predominant breast cancer is a new predictor for pathological complete response to neoadjuvant chemotherapy
    Ishikawa, Satoko
    Inokuchi, Masafumi
    Hayashi, Hironori
    Oyama, Katsunobu
    Nakagawara, Hisatoshi
    Miyashita, Tomoharu
    Tajima, Hidehiro
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Kitagawa, Hirohisa
    Fushida, Sachio
    Fujimura, Takashi
    Ohta, Tetsuo
    CANCER RESEARCH, 2015, 75
  • [39] MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy
    Li, Yan-Ling
    Zhang, Xiao-Peng
    Li, Jie
    Cao, Kun
    Cui, Yong
    Li, Xiao-Ting
    Sun, Ying-Shi
    EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (02) : 242 - 249
  • [40] Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer
    Patricia Cortazar
    Charles E. Geyer
    Annals of Surgical Oncology, 2015, 22 : 1441 - 1446
12345